SUMMARY A 62 year old woman with primary biliary cirrhosis was found to have a plasma sodium concentration of 115 mmol/l. Follow up showed this to be a "pseudohyponatraemia" due to a massively raised serum cholesterol concentration of78 mmol/l. Electrophoresis ofserum lipoproteins and of the lipoproteins and apolipoprotiens in fractions isolated on density-gradient ultracentrifugation showed that the major portion of the serum cholesterol was being transported with lipoprotein-X. Low density lipoprotein-cholesterol concentration was also raised. Lipoprotein-X contained, in addition to albumin and apolipoprotein C, apolipoprotein E. This case is of interest because of the degree of hypercholesterolaemia, its association with pseudohyponatraemia, and the unequivocal demonstration of apolipoprotein E associated with lipoprotein-X.
Primary biliary cirrhosis is a disease of unknown aetiology, characterised by gradual destruction of bile ducts, and leading to hepatocyte loss and liver scarring. Among the many laboratory features that may accompany it are increases in serum lipid concentrations, especially ofcholesterol. Cholesterol concentrations are invariably above the reference range and may be as high as 15 mmol/l.'
We report a case of primary biliary cirrhosis in which follow up ofa low plasma sodium concentration led to the finding of a massively raised cholesterol concentration of 78 mmol/l.
Material and methods
Electrolytes and liver function tests were measured on a SMAC II AutoAnalyzer (Technicon Equipment, Sydney, Australia) with Technicon reagents and methods. Sodium and potassium were also measured on a Corning Model 902 Na/K Analyzer (Corning Instruments, Halstead, Essex, England). Coefficients ofvariation (CVs) for sodium were I-3% at 115 mmol/ 1 and 0 8% or less at 155 mmol/l.
Serum cholesterol and triglyceride concentrations were measured on a Cobas Mira (Roche Diagnostics, Sydney, Australia) discrete analyser, using A-gent reagents (Abbott Laboratories, Irving, Texas). CVs for cholesterol at three control levels were better than 3%. The lipid assays were standardised using Lipoprotein electrophoresis of unfractionated serum (fig 2, column 8) showed a dense band lying cathodal to the usual low density lipoprotein (LDL) position, and corresponding to the reported position of lipoprotein-X.5 Density-gradient ultracentrifugation was performed and the fractions isolated were subjected to lipoprotein electrophoresis as shown in fig 2, columns 1 to 7 . The LDL and lipoprotein-X segregated predominantly into the fractions ofdensity 1-029 and 1 069 kg/l, respectively (fig 2, columns 2  and 3 ).
Results
The cholesterol content ofeach fraction was estimated and the results are shown in the Volumes were determined by aspirating fractions into tared tubes and calculating from mass and determined density. Recovery of cholesterol was more than 99%. Although lipoprotein-X was isolated without contamination from LDL, the fraction containing LDL held a considerable quantity of lipoprotein-X. Measurement of the serum apoB concentration gave a value of 2-9 g/l (reference range < 1 0 g/l), suggesting that the cholesterol carried by LDL contributed about 10 mmol/16 to the total serum cholesterol concentration and that by lipoprotein-X most of the remainder. It should be noted that this specimen was collected four weeks after the original specimen at which time the total cholesterol concentration was 64-8 mmol/l. SDS-polyacrylamide gel electrophoresis was performed on the fractions separated by density gradient ultracentifugation (fig 3) . The two patient fractions of interest are shown in columns 10 and 1 1. The fraction run in column 10 contains no apoB and therefore no LDL and corresponds to column 3 in fig 2. This fraction does, however, contain apoC, apo A-I, apoE and albumin. The fraction run in column 11 contains LDL as shown by the presence of apoB and corresponds to column 2 in fig 2. This fraction also contains apoC, apoA, apoE and albumin, suggesting that it contains both LDL and lipoprotein-X. Albumin was clearly associated with lipoprotein-X but did not appear in the adjacent fractions (data not shown), implying that albumin was an integral part of the lipoprotein-X particle and not an artefact.
Discussion
Primary biliary cirrhosis is a disease of unknown aetiology, characterised by the gradual destruction of bile ducts and leads to hepatocyte loss and liver scarring. This patient had an unequivocal diagnosis of primary biliary cirrhosis based on clinical, laboratory, and biopsy data.
Hypercholesterolaemia is common in primary biliary cirrhosis with concentrations up to 15 mmol/l being reported.' We are not aware of any reports of serum cholesterol concentrations raised to the degree seen in the present case.
The term pseudohyponatraemia refers to the apparently low sodium concentration found in plasma when blood specimens with high concentrations of either lipid or protein are analysed by either a flame photometer or an ion-selective electrode that requires sample dilution before assay. Proteins and lipids are large molecules, which effectively reduce the water space of plasma (in which sodium is present). Flame photometers measure the amount of electrolyte in a given volume of plasma, without making any correction for variations in plasma water content that may Grossly increased concentrations of triglyceride are commonly associated with pseudohyponatraemia. Increases in serum cholesterol concentration to a degree sufficient to cause pseudohyponatraemia must be very uncommon, and the case reported here may be a unique presentation.
Lipoprotein-X is a variant lipoprotein which is seen in patients with biliary obstruction and with deficiency of the enzyme lecithin-cholesterol acyl-transferase.9 It contains high concentrations offree cholesterol bound to apolipoprotein, phospholipid, and albumin. There has been some controversy about the apolipoprotein composition of lipoprotein-X. It has been reported that lipoprotein-X contains apoE as well as apoC'°but Seidel's recent review" states that apoE is not a component of lipoprotein-X. After density-gradient ultracentrifugation which clearly isolated lipoprotein-X we found unequivocal presence of a protein with molecular weight identical with apoE. The reasons for the apparent disagreement between our work and that of Seidel may be: (1) the concentration of lipoprotein-X from our patient is so high that we are able to identify minor species with greater ease; (2) some of the earlier studies used experimental biliary ligation of short term duration to generate their lipoprotein-X, and these artificial conditions may produce different species to those that occur naturally.
We are not able to state exactly how much cholesterol was carried by lipoprotein-X and by LDL, respectively. ApoB concentration was significantly increased with only a minor increase in very low density lipoprotein (the serum triglyceride concentration was 3 5 mmol/l), implying that LDL-cholesterol concentration was also increased. Based on the chemical composition of LDL,6 the LDL-cholesterol was estimated at about 10 mmol/l, a concentration associated with a much increased risk of cardiovascular disease.'2 The very high serum concentrations of cholesterol seen in this patient raise the question whether there might be some other factor acting with the primary biliary cirrhosis to produce this degree of hypercholesterolaemia, such as familial hypercholesterolaemia or other genetic hyperlipidaemia. We have not been able to carry out a family study to find support for this suggestion. Our patient was being considered for hepatic transplantation, but was considered unlikely to be accepted because ofconsiderable ischaemic heart disease.
